We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2.26B
AUM Growth
+$299M
Cap. Flow
+$214M
Cap. Flow %
9.45%
Top 10 Hldgs %
6.6%
Holding
1,916
New
614
Increased
388
Reduced
316
Closed
591

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$16.7M
2
NFLX icon
Netflix
NFLX
+$14.1M
3
USB icon
US Bancorp
USB
+$12.4M
4
GE icon
GE Aerospace
GE
+$11.7M
5
CHTR icon
Charter Communications
CHTR
+$11.4M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$23M
2
ABBV icon
AbbVie
ABBV
+$18.8M
3
INTU icon
Intuit
INTU
+$13.1M
4
TXN icon
Texas Instruments
TXN
+$12.6M
5
BKNG icon
Booking.com
BKNG
+$10.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.57%
2 Industrials 13.56%
3 Technology 13.35%
4 Healthcare 13.31%
5 Financials 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNVR
1751
DELISTED
Univar Solutions Inc.
UNVR
-20,599
Closed -$595K
SPPI
1752
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-27,538
Closed -$387K
AJRD
1753
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-11,977
Closed -$419K
GLOP
1754
DELISTED
GASLOG PARTNERS LP
GLOP
-10,600
Closed -$246K
JNCE
1755
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-18,064
Closed -$281K
BSMX
1756
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
-47,500
Closed -$479K
AUY
1757
DELISTED
Yamana Gold, Inc.
AUY
-30,930
Closed -$81K
SRNE
1758
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-123,455
Closed -$209K
REED
1759
DELISTED
Reeds, Inc. Common Stock
REED
-301
Closed -$33K
VIVO
1760
DELISTED
Meridian Bioscience Inc
VIVO
-25,700
Closed -$367K
HIL
1761
DELISTED
Hill International, Inc. Common Stock
HIL
-25,914
Closed -$123K
AGTC
1762
DELISTED
Applied Genetic Technologies Corporation
AGTC
-12,585
Closed -$49K
PBFX
1763
DELISTED
PBF LOGISTICS LP
PBFX
-14,873
Closed -$312K
ZEN
1764
DELISTED
ZENDESK INC
ZEN
-56,400
Closed -$1.64M
CFMS
1765
DELISTED
Conformis, Inc. Common Stock
CFMS
-1,275
Closed -$112K
Y
1766
DELISTED
Alleghany Corp
Y
-1,710
Closed -$947K
TMX
1767
DELISTED
Terminix Global Holdings, Inc.
TMX
-44,491
Closed -$1.39M
MBII
1768
DELISTED
Marrone Bio Innovations, Inc.
MBII
-23,171
Closed -$26K
WMC
1769
DELISTED
Western Asset Mortgage Capital Corporation
WMC
-1,690
Closed -$176K
SRRA
1770
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-567
Closed -$35K
ZNGA
1771
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-251,190
Closed -$949K
MIME
1772
DELISTED
Mimecast Limited
MIME
-30,753
Closed -$874K
DISCK
1773
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-87,200
Closed -$1.77M
PVG
1774
DELISTED
PRETIUM RESOURCES INC.
PVG
-120,430
Closed -$1.11M
CSLT
1775
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
-26,009
Closed -$111K

Similar funds

A.R.T. Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, A.R.T. Advisors held 1,916 positions worth $2.26B, up 15% from $1.96B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

A.R.T. Advisors deployed $214M of net new capital in Q4 2017, opening 614 new positions and adding to 388 existing holdings. Its largest new stake was IBM: 114,615 shares worth $16.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $18.8M trimmed.

  • A.R.T. Advisors's largest Q4 2017 buy was IBM: 114,615 shares worth $16.8M.
  • A.R.T. Advisors added most to Netflix in Q4 2017, an estimated $14.1M increase.
  • A.R.T. Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $18.8M.
  • A.R.T. Advisors fully exited Celgene Corp in Q4 2017, selling an estimated $23M.
  • A.R.T. Advisors's ten largest holdings make up 6.6% of its $2.26B portfolio in Q4 2017.
  • A.R.T. Advisors opened 614 new positions and closed 591 in Q4 2017.
  • A.R.T. Advisors's portfolio value rose 15% quarter-over-quarter to $2.26B.

Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.